Position in NRXS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$103,611
New position
Shares Held
14,174
first reported quarter
Ownership
0.113%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#23
of 32 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026OCCUDO QUANTITATIVE STRATEGIES LP holds $17,746,206 across 12 Biotechnology names. NRXS ranks #11 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
165,177 | $9,261,474 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
10,490 | $2,567,637 | |
| 3 | TARS |
Tarsus Pharmaceuticals, Inc.
|
29,659 | $1,866,737 | |
| 4 | ARVN |
Arvinas, Inc.
|
124,648 | $1,035,824 | |
| 5 | LENZ |
LENZ Therapeutics, Inc.
|
146,376 | $831,415 | |
| 6 | NKTR |
Nektar Therapeutics
|
11,074 | $773,075 | |
| 7 | ALMS |
Alumis Inc.
|
15,297 | $430,457 | |
| 8 | PHVS |
Pharvaris N.V.
|
11,365 | $393,001 |
All Filings in NRXS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $103,611 | 14,174 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||